TRUGLIF 25MG TAB

TRUGLIF 25MG contains empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor used to manage type 2 diabetes mellitus. It works by increasing glucose excretion through urine, helping to lower blood sugar levels effectively. Each tablet delivers 25mg of empagliflozin for once-daily oral administration. This medication is suitable for patients seeking improved glycemic control and may offer additional cardiovascular and renal protective benefits. Always take as prescribed by your healthcare provider. Store in a cool, dry place away from moisture and direct sunlight. Consult your doctor before use if you have kidney disease, urinary tract infections, or are pregnant or breastfeeding.